Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)
Clinical trial NCT05233618 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05233618
- Sponsor
- Karen Ballen, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-13
- Primary completion
- 2026-10-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.